ZHANG Junying. Characteristics of intestinal microflora in patients with chronic obstructive pulmonary disease and its correlation with inflammatory indexes and pulmonary function[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 51-54. DOI: 10.7619/jcmp.201924016
Citation: ZHANG Junying. Characteristics of intestinal microflora in patients with chronic obstructive pulmonary disease and its correlation with inflammatory indexes and pulmonary function[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 51-54. DOI: 10.7619/jcmp.201924016

Characteristics of intestinal microflora in patients with chronic obstructive pulmonary disease and its correlation with inflammatory indexes and pulmonary function

More Information
  • Received Date: October 10, 2019
  • Accepted Date: November 09, 2019
  • Available Online: February 28, 2021
  • Published Date: December 27, 2019
  •   Objective  To explore the characteristics of intestinal microflora in patients with chronic obstructive pulmonary disease (COPD) and its correlation with inflammatory indexes and pulmonary function.
      Methods  A total of 104 patients with COPD were selected as observation group, and 80 healthy people were selected as control group. The intestinal microflora was compared between two groups. The serum levels of high sensitive C reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α) andinterleukin-6 (IL-6) were compared between two groups. The forced expiratory volume in the first second as a percentage of the expected value (FEV1%) and the ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC) were compared between two groups. Correlation between the characteristics of intestinal microflora and inflammatory indexes as well as pulmonary function were analyzed.
      Results  Compared with the control group, there was no significant change in the type of aerobic bacteria in the observation group, and the number of clostridium in the anaerobic bacteria was significantly higher than that in the control group (P < 0.05). The number of fungi in the observation group was more than that in the control group. The numbers of bifidobacteria and lactobacilli (feces) in the observation group were significantly lower than those in the control group (P < 0.05). The levels of serum hs-CRP, TNF-α and IL-6 in the observation group were significantly higher than those in the control group (P < 0.05). FEV1/FVC and FEV1% in the observation group were significantly lower than those in the control group (P < 0.05). Pearson correlation analysis showed that there were significant negative correlations between bifidobacteria and FEV1/FVC, FEV1%, hs-CRP, TNF-α, IL-6 (r=-0.524、-0.498、-0.477、-0.512、-0.508, P < 0.05), and lactobacilli was also negatively correlated with FEV1/FVC, FEV1%, hs-CRP, TNF-α, IL-6 (r=-0.576、-0.466、-0.442、-0.523、-0.439, P < 0.05).
      Conclusion  There is a significant negative correlation between intestinal microflora and inflammatory indexes and pulmonary function in COPD patients.
  • [1]
    单怡凡, 李慧君, 吴辉, 等. 肠道微生物与慢性阻塞性肺疾病和哮喘相关性研究进展[J]. 新乡医学院学报, 2018, 35(10): 934-936. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYX201810023.htm
    [2]
    卢雯莉, 漆冬梅. 基于肠道菌群失调的益生菌对COPD伴腹泻患者的干预效果观察[J]. 慢性病学杂志, 2018, 19(11): 1609-1611. https://www.cnki.com.cn/Article/CJFDTOTAL-YYSO201811052.htm
    [3]
    罗倩. COPD加重期患者肺功能、血气指标及炎症指标的变化分析[J]. 医学信息, 2018, 31(9): 114-116. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXX201809034.htm
    [4]
    张云云, 谢翔. 中重度COPD患者肺功能、炎症状况及临床治疗分析[J]. 湖南师范大学学报: 医学版, 2018, 15(3): 119-122. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYG201803036.htm
    [5]
    李军民, 白晓, 孟茜, 等. COPD患者血清降钙素原水平与肺功能的关系研究[J]. 现代检验医学杂志, 2018(1): 148-150. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYN201801039.htm
    [6]
    史琦, 王辛秋, 孔艳华, 等. 浅述慢性阻塞性肺疾病与肠道菌群微生态失衡的关系[J]. 世界中西医结合杂志, 2016, 11(5): 732-736. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201605039.htm
    [7]
    张鑫, 熊叶, 马可, 等. 肺部菌群与慢性阻塞性肺疾病[J]. 中国实用内科杂志, 2017, 37(8): 769-771. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201708031.htm
    [8]
    周瑶, 宁华诚, 黄瑞雪. 肺部菌群和肠道菌群在两种常见肺疾病中作用的研究进展[J]. 中国微生态学杂志, 2019, 31(6): 740-744. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201906030.htm
    [9]
    王传玉, 吴文汇, 郭健, 等. 常规肺功能检查对COPD相关性肺动脉高压的筛查和评估价值[J]. 国际呼吸杂志, 2019(4): 281-288.
    [10]
    佟岩, 张玉华. 慢性阻塞性肺疾病患者肺功能与高分辨率CT影像学的相关性[J]. 武警后勤学院学报: 医学版, 2017, 26(4): 309-313. https://www.cnki.com.cn/Article/CJFDTOTAL-WUXB201704009.htm
    [11]
    孙晓燕, 刁文琦, 刘贝贝, 等. COPD血清生物标志物水平和在气流受限中的作用[J]. 国际呼吸杂志, 2017(9): 653-658.
    [12]
    陈蔚, 卫英, 涂春莲. 老年住院患者细菌耐药检测和抗菌药物使用分析[J]. 实用临床医药杂志, 2013, 17(3): 93-95. doi: 10.7619/jcmp.201303030
    [13]
    杨秀娜, 杨梅, 刘新会, 等. 慢性阻塞性肺疾病患者血清IL-13、TGF-α浓度变化及其肺功能相关性研究[J]. 实用预防医学, 2017, 24(1): 92-94. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYY201701029.htm
    [14]
    罗广彬. 血浆BNP水平和血清hs-CRP水平检测在不同程度COPD中临床应用[J]. 国际检验医学杂志, 2017, 38(6): 838-840. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSQ201706046.htm
    [15]
    金文静, 谢晓洪, 朱念. 外周血Th9和IL-9水平在COPD发病中的作用[J]. 热带医学杂志, 2017, 17(9): 1177-1180. https://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ201709013.htm
  • Cited by

    Periodical cited type(5)

    1. 洪玫,段宏宪,杨敏. 清肝化湿活血汤联合复方甘草酸苷片治疗酒精性肝病的临床疗效及对患者肝功能的影响. 医药论坛杂志. 2023(02): 87-89+93 .
    2. 王箭焱. 舒肝宁注射液联合复方甘草酸苷对非酒精性脂肪性肝炎患者脂代谢、肝功能的影响. 中国医学创新. 2023(22): 45-48 .
    3. 陈凯,孟祥林. 多烯磷脂酰胆碱注射液对自身免疫性肝炎患者肝功能指标的影响. 中国药物与临床. 2023(10): 665-669 .
    4. 罗萍,蒋玲,刘杨武. 甘草酸制剂治疗病毒性肝炎的效果观察. 继续医学教育. 2022(04): 145-148 .
    5. 李斌,王磊. 舒肝消癖颗粒联合复方甘草酸苷片治疗非酒精性脂肪肝的临床效果及对肝功能的影响. 反射疗法与康复医学. 2022(07): 8-10 .

    Other cited types(1)

Catalog

    Article views PDF downloads Cited by(6)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return